Drug Profile
GSK 729327
Alternative Names: 729327; GSK729327Latest Information Update: 01 Aug 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antipsychotics
- Mechanism of Action AMPA receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 28 Apr 2011 No development reported - Phase-I for Schizophrenia in Germany (PO)
- 28 Apr 2011 No development reported - Phase-I for Schizophrenia in United Kingdom (PO)
- 13 Mar 2007 Phase-I clinical trials in Schizophrenia in United Kingdom (PO)